Nectar Lifesciences
NECLIFE.NS
#10766
Rank
โ‚น1.98 B
Marketcap
โ‚น10.21
Share price
-2.76%
Change (1 day)
-28.09%
Change (1 year)

Revenue for Nectar Lifesciences (NECLIFE.NS)

Revenue in 2026 (TTM): โ‚น50.11 Million

According to Nectar Lifesciences 's latest financial reports the company's current revenue (TTM ) is โ‚น54.3 Million. In 2025 the company made a revenue of โ‚น49.96 Million a decrease over the revenue in the year 2024 that were of โ‚น8.04 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Nectar Lifesciences from 2019 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น50.11 M0.29%
2025 โ‚น49.96 M-99.38%
2024 โ‚น8.04 B-50.71%
2023 โ‚น16.32 B1.25%
2022 โ‚น16.12 B4.53%
2021 โ‚น15.42 B-12.31%
2020 โ‚น17.58 B-32.29%
2019 โ‚น25.97 B